Efficacy of in Vitro Fertilization After Chemotherapy
Overview
Affiliations
Objective: To evaluate if in vitro fertilization (IVF) with embryo cryopreservation can be proposed to patients immediately after one or two regimens of chemotherapy.
Design: Retrospective study.
Setting: Academic research center and IVF unit.
Patient(s): Eleven young patients diagnosed with cancer between September 1999 and April 2003 who wanted to preserve their fertility via IVF.
Intervention(s): Stimulation and IVF before or soon after chemotherapy treatment.
Main Outcome Measure(s): The number and quality of embryos obtained after stimulation in cancer patients undergoing IVF before or soon after chemotherapeutic treatment.
Result(s): Four patients underwent IVF in the interval between two regimens of chemotherapy. Two of them had no follicular development; one underwent follicular puncture but no oocytes were retrieved; and, in one, six oocytes were harvested but only one good quality embryo was obtained. In the seven patients who underwent IVF before starting chemotherapy, between 4 and 11 embryos were obtained per patient, the majority being good quality embryos.
Conclusion(s): Because the efficacy of IVF is dramatically reduced after even one round of chemotherapy, IVF should be performed before chemotherapy. For those who require immediate chemotherapy, ovarian tissue cryopreservation and/or oocyte cryopreservation could be used before treatment.
Molecular Mechanisms Determining Mammalian Oocyte Quality with the Treatment of Cancer Therapy.
Dong R, Abazarikia A, Luan Y, Yu S, Kim S Adv Anat Embryol Cell Biol. 2024; 238:97-119.
PMID: 39030356 DOI: 10.1007/978-3-031-55163-5_5.
Fertility preservation before and after cancer treatment in children, adolescents, and young adults.
Yang E, Strohl H, Su H Cancer. 2023; 130(3):344-355.
PMID: 37962199 PMC: 10841998. DOI: 10.1002/cncr.35108.
Assisted reproductive technology use and outcomes in childhood cancer survivors.
Keefe K, Lanes A, Stratton K, Green D, Chow E, Oeffinger K Cancer. 2023; 130(1):128-139.
PMID: 37732943 PMC: 10841316. DOI: 10.1002/cncr.34995.
Grubliauskaite M, van der Perk M, Bos A, Meijer A, Gudleviciene Z, van den Heuvel-Eibrink M Cancers (Basel). 2023; 15(17).
PMID: 37686475 PMC: 10486797. DOI: 10.3390/cancers15174199.
Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S, Yamada M, Yano R, Takahashi K, Ebara A, Sakanaka H J Ovarian Res. 2023; 16(1):159.
PMID: 37563616 PMC: 10416401. DOI: 10.1186/s13048-023-01250-x.